Nanordica Medical, based in Tallinn, is a promising player in health technology, focusing on advanced antibacterial wound dressings. Utilizing cutting-edge technologies, their products aim to reduce infection risks, enhance healing times, and lower medical costs compared to traditional wound care solutions. Supported by investors like Superangel and Specialist VC, Nanordica Medical is positioned to disrupt the wound care market by addressing key gaps in infection prevention and wound healing, paving the way for strong growth amid rising demand for effective healthcare solutions.